MVM
GILD icon

McClain Value Management’s Gilead Sciences GILD Stock Holding History

McClain Value Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,554
Closed -$2.83M – 25
2017
Q4 		$2.83M Sell
39,554
-252
-0.6% -$19.1K 3.74% 18
2017
Q3 		$3.23M Sell
39,806
-1,560
-4% -$119K 4.54% 10
2017
Q2 		$2.93M Sell
41,366
-3,809
-8% -$253K 3.78% 14
2017
Q1 		$3.07M Buy
+45,175
New +$3.18M 3.94% 14

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McClain Value Management's GILD Position: Q1 2018 in Review

McClain Value Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 39,554 shares — an estimated $2.83M sold.

McClain Value Management first reported a position in GILD in Q1 2017 and held it in 4 quarters. The position peaked at $3.23M in Q3 2017. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • McClain Value Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • McClain Value Management sold 39,554 Gilead Sciences shares in Q1 2018, an estimated $2.83M.
  • McClain Value Management first reported a position in Gilead Sciences in Q1 2017 and held it in 4 quarters.
  • McClain Value Management's Gilead Sciences position peaked at $3.23M in Q3 2017.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on McClain Value Management's 13F filing for Q1 2018, filed 7 May 2018.